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Using micro technology in process screening 
for improved ω-transaminases  
Introduction:  
Today, optically pure chiral amines are particularly important intermediates in a broad 
range of pharmaceuticals[1].  Biocatalysts provide the possibility of having high selec-
tivity combined with mild reaction conditions and simplified downstream processing
[2, 3]. One biocatalyst of interest for this synthesis is ω-transaminase, which provides a 
unique opportunity towards the asymmetric production of optical pure chiral amines, 
with >99 % e.e., compared to conventional methods (scheme 1).                   
     
 
 
 
 
Scheme 1: The asymmetric synthesis of optically pure chiral amines from an amine donor and matching ketone. 
A big hindrance to the industrial implementation of ω-transaminase is the unfavorable 
equilibrium[3]. This can partly be circumvented by smart process engineering, but it 
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Figure 1— Flowsheets that can be used as a basis to op-
timise reactor performance, ISSS—In-situ substrate 
supply, ISPR—in-situ product removal, IScPR—in-situ 
co-product removal, Cascade– cascade enzymes 
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can only be expected to handle part of the problem. It is therefore highly desired 
to implement process considerations at an early stage in the overall process de-
velopment, including integration with protein engineering. A recent review by 
Bornscheuer and co-workers.[4] describes the impressive contribution that pro-
tein engineering can make in process implementation. A key requirement is the 
further development of effective analytical tools that will be able to handle the 
“smarter” libraries that today are smaller (103 samples), but with a higher chan-
ce of finding the right mutant, compared to the past (105 samples).  In general it 
is now possible and of great importance to rethink the disposition of work bet-
ween protein and process engineers. Today it is clear that the two fields can 
complement each others weaknesses. The strategies  of process engineering with 
regard to reaction optimisation  are illustrated in Figure 1 and 2. In Figure 2 the strate-
gies for direct protein engineering are also shown. 
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In Figure 1 the schemes has been made according to donor (MBA, IPA or ALA), and 
displays operations by color coding. A complete overview of the strategies can be se-
en in Table 1. Direct protein engineering affects the rate and the selectivity of the pro-
tein, whereas in-direct affects the stability and optimal environment.  
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Figure 2— The different strategies of process engineering and direct protein 
engineering. 
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Table 1— Overview of the different strategies 
